← The Wire
TOVXNYSE
Theriva Biologics, Inc.
Pharmaceutical Preparations · NV · CIK 894158
Developing oncolytic adenovirus therapeutics to treat cancer and related diseases
$14M
Market cap
$0.26
Last close
+4.1%
1D
+2.8%
5D
1.2M
Volume
Price · last 39 sessions-31.5%
May 4L $0.24 · H $0.38Jun 29
572
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
DEF 14ADEF 14AJun 29, 20268-KReg FD Disclosure · Company UpdateJun 11, 20268-KCompany UpdateJun 5, 202610-Q10-QMay 5, 20268-KResults of OperationsMay 5, 2026DEF 14ADEF 14AApr 30, 20268-KReg FD Disclosure · Company UpdateApr 17, 20268-KCompany UpdateApr 9, 20268-KReg FD Disclosure · Company UpdateMar 23, 2026DEF 14ADEF 14AMar 16, 202610-K10-KMar 12, 20268-KResults of OperationsMar 12, 20268-KMaterial Agreement · Reg FD DisclosureFeb 18, 20268-KCompany UpdateFeb 12, 20268-KCompany UpdateJan 12, 2026DEF 14ADEF 14AJan 5, 20268-KReg FD Disclosure · Company UpdateDec 29, 20258-KCompany UpdateDec 15, 2025424B5424B5Dec 3, 2025DEFA14ADEFA14ANov 12, 202510-Q10-QNov 12, 20258-KResults of OperationsNov 12, 2025DEF 14ADEF 14ANov 10, 20258-KCompany UpdateOct 29, 2025424B5424B5Oct 29, 20258-KCompany UpdateOct 24, 2025424B5424B5Oct 24, 20258-KCompany UpdateOct 20, 20258-KMaterial Agreement · Equity IssuanceOct 17, 2025424B5424B5Oct 16, 2025424B5424B5Oct 16, 2025424B5424B5Oct 16, 2025424B5424B5Oct 16, 20258-KReg FD Disclosure · Company UpdateOct 14, 20258-KCompany UpdateOct 8, 20258-KReg FD Disclosure · Company UpdateOct 6, 20258-KExit / Disposal CostsOct 2, 20258-KExecutive Change · Shareholder VoteSep 4, 202510-Q10-QAug 11, 20258-KResults of OperationsAug 11, 2025DEF 14AFORM DEF 14AJul 9, 20258-KCompany UpdateJun 25, 20258-KCompany UpdateJun 20, 2025424B5424B5Jun 20, 20258-KReg FD Disclosure · Company UpdateJun 2, 202510-Q10-QMay 14, 20258-KResults of OperationsMay 14, 20258-KMaterial Agreement · Company UpdateMay 8, 2025424B5424B5May 8, 20258-KReg FD Disclosure · Company UpdateMay 7, 20258-KReg FD Disclosure · Company UpdateMar 31, 2025S-1/AFORM S-1/AMar 21, 202510-K10-KMar 6, 20258-KResults of OperationsMar 6, 2025S-1/AFORM S-1/AJan 21, 2025S-1FORM S-1Dec 10, 20248-KReg FD Disclosure · Company UpdateDec 5, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 20248-KExecutive Change · Bylaw AmendmentNov 1, 20248-KReg FD Disclosure · Company UpdateOct 16, 2024SC 13GSCHEDULE 13GOct 3, 20248-KReg FD Disclosure · Company UpdateOct 3, 2024SC 13GSC 13GOct 2, 2024DEF 14ADEF 14ASep 30, 20248-KMaterial Agreement · Company UpdateSep 30, 2024424B5424B5Sep 27, 2024424B5424B5Sep 26, 2024S-1/AFORM S-1/ASep 23, 20248-KReg FD Disclosure · Company UpdateSep 23, 20248-KNew Debt / Obligation · Reg FD DisclosureSep 16, 2024S-1FORM S-1Sep 10, 20248-KCompany UpdateSep 9, 20248-KSecurity-Holder Rights · Bylaw AmendmentAug 26, 20248-KSecurity-Holder Rights · Bylaw AmendmentAug 16, 202410-Q10-QAug 13, 20248-KResults of OperationsAug 13, 20248-KReg FD Disclosure · Company UpdateJul 31, 20248-KReg FD Disclosure · Company UpdateMay 23, 20248-KCompany UpdateMay 16, 2024
Similar companies
Comparable business profile · signals at a glance